Login
$IRWD
$4.76 -$0.09 (1.85%) After hours

Company Executives

Officer Age In this role Joined Source
Thomas McCourt Also a director
Chief Executive Officer
Title from the Form 4 dated Mar 10, 2026
Not stated Not stated Not stated
Tammi Gaskins
Senior Vice President, Chief Commercial Officer
53 Since 2025
1 year
2020
John Minardo
Senior Vice President, Chief Legal Officer and Secretary
51 Since 2021
5 years
2021
Michael Shetzline
Senior Vice President, Chief Medical Officer and Head of Research and Drug Development
67 Not stated 2019
Jeffrey Silber
SVP, CMO, Head-Res&Drug
Title from the Form 4 dated Jul 20, 2026
Not stated Not stated Not stated
Ronald Silver
PFO & PAO
Title from the Form 4 dated Jul 7, 2026
Not stated Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Director 2025 pay Source
Mark Currie
Not stated
Alexander Denner
Not stated
Jon Duane
$100,960
Marla Kessler
$95,960
Thomas McCourt
Not stated
Julie McHugh
$136,960
Catherine Moukheibir
$110,960
Jay Shepard
$96,960

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 28, 2026
each of our current directors and executive officers
current directors and our executive officers
Amount not stated

Indemnification agreements requiring the company to indemnify them to the fullest extent permitted under Delaware law and to advance expenses.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support